Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Benzaquen Michael; Borradori Luca; Berbis Philippe; Cazzaniga Simone; Valero Rene; Richard Marie-Aleth; Feldmeyer Laurence

首页> 外文期刊>Journal of the American Academy of Dermatology >Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

【24h】

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

机译：二肽基肽酶IV抑制剂，大容易的肺泡的危险因素：来自法国和瑞士的回顾性多中心病例对照研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Case reports have suggested an association between dipeptidyl peptidase-4 inhibitors (DPP4is) and development of bullous pemphigoid (BP).

机译：背景：案例报告表明二肽基肽酶-4抑制剂（DPP4）和大疱性毒性发育（BP）之间的关联。

著录项

来源
《Journal of the American Academy of Dermatology》 |2018年第6期|共7页
作者
Benzaquen Michael; Borradori Luca; Berbis Philippe; Cazzaniga Simone; Valero Rene; Richard Marie-Aleth; Feldmeyer Laurence;
展开▼
作者单位

Aix Marseille Univ Hop Nord Assistance Publ Hop Marseille Dept Dermatol Chemin Bourrely F;

Aix Marseille Univ Hop Nord Assistance Publ Hop Marseille Dept Dermatol Chemin Bourrely F;

Aix Marseille Univ Hop Nord Assistance Publ Hop Marseille Dept Dermatol Chemin Bourrely F;

Aix Marseille Univ Hop Nord Assistance Publ Hop Marseille Dept Dermatol Chemin Bourrely F;

Ctr Studi GISED Bergamo Italy;

Aix Marseille Univ Assistance Publ Hop Marseille Hop de la Conception INRA 1260 INSERM 1062 Dept;

Aix Marseille Univ Hop Nord Assistance Publ Hop Marseille Dept Dermatol Chemin Bourrely F;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词
bullous pemphigoid; case-control study; diabetes; dipeptidyl peptidase-4 inhibitor; gliptin; risk factor;

机译：大疱的薄膜;病例对照研究;糖尿病;二肽肽肽酶-4抑制剂;Plipin;危险因素;

相似文献

外文文献
中文文献
专利

1. Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland [J] . Benzaquen Michael, Borradori Luca, Berbis Philippe, Journal of the American Academy of Dermatology . 2018,第6期

机译：二肽基肽酶IV抑制剂，大容易的肺泡的危险因素：来自法国和瑞士的回顾性多中心病例对照研究
2. Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study'' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid [J] . Schwager Zachary, Mikailov Anar, Lipworth Adam D. Journal of the American Academy of Dermatology . 2019,第6期

机译：评论“除了二肽基肽酶-4抑制剂以外的口腔糖尿病药物与大疱性疱疹病毒（Dellous Pemphigoid）无关：芬兰国家病例对照研究”“和胰高血糖素肽-1受体激动剂诱导的大疱病毒诱导的大疱病
3. Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database [J] . Bene J., Moulis G., Bennani I., British Journal of Dermatology . 2016,第2期

机译：大疱性类天疱疮和二肽基肽酶IV抑制剂：法国药物警戒数据库中的非病例研究
4. Classification analysis using support vector machine, decision tree, and neural network with principal component analysis to determine molecular structure relationship from its biological activity on dipeptidyl peptidase IV inhibitors [C] . Haris Hamzah, Alhadi Bustamam, Arry Yanuar, International Conference on Science and Applied Science . 2020

机译：使用支撑向量机，决策树和神经网络具有主成分分析的分类分析，从而确定二肽基肽酶IV抑制剂的生物活性分子结构关系
5. Screening, Extraction, Isolation and Characterization of a Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor From Ayurvedic and Chinese Herbs [D] . Dai, Fangteng 2018

机译：阿育吠陀和中草药中二肽基肽酶-IV（DPP-IV）抑制剂的筛选，提取，分离和表征
6. Dipeptidyl peptidase‐4 inhibitors‐associated bullous pemphigoid: A retrospective study of 168 pemphigoid and 9304 diabetes mellitus patients [O] . Yohei Kawaguchi, Risa Shimauchi, Nobuhiro Nishibori, 2019

机译：二肽基肽酶-4抑制剂相关的大疱性类天疱疮：168例天疱疮和9304例糖尿病患者的回顾性研究
7. Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland [O] . Michael Benzaquen, Luca Borradori, Philippe Berbis, 2018

机译：二肽肽肽酶IV抑制剂，大容易的毒性危险因素：法国和瑞士的回顾性多中心病例对照研究

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

摘要

著录项

相似文献

相关主题

期刊订阅